My guess is either waiting for a deal which is attractive to the company or if not attractive, holding off until results come in for COVID-19 x 2 clinical trials. A positive result in either trial will put them in a better bargaining position. Even the India market alone is massive tempered with a fair price arrangement. DYOR
DXB Chart, page-122
-
- There are more pages in this discussion • 867 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
56.0¢ |
Change
-0.010(1.75%) |
Mkt cap ! $313.3M | |||
| Open | High | Low | Value | Volume |
| 56.0¢ | 56.5¢ | 55.0¢ | $724.0K | 1.298M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12200 | 56.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 56.5¢ | 18476 | 3 |
View Market Depth
| Last trade - 10.09am 19/06/2024 (20 minute delay) ? |
| DXB (ASX) Chart |